Immatics presenting at Hanson Wade TCR-based Therapies Summit
Jun 08 - Jun 10, 2021
Join Immatics at the TCR-based Therapies Summit (June 8-10) which is dedicated to supercharging TCR design, translation and manufacturing strategy for solid tumor success . Thus, don’t miss to join Immatics virtually:
Thursday, June 10, 3:30pm – 4:00pm EST
Session Increasing Efficacy of TCRs to Optimize Next Generation Immunotherapy
Presentation “Exploring Novel Approaches to Reducing Manufacturing Cost and Time”
• Maximizing T cell quality to increase efficacy, lower required cell counts and reduce the cost of manufacturing
• Exploring innovative manufacturing methods during process development, to seamlessly scale up and improve processes post approval with minimal costs
Speaker: Ali Mohamed, VP CMC Immatics
We are looking forward to e-meeting you!
Learn more about the TCR-based Therapies Summit 2021 here.